Showing results (71-80 of 105) with videos related to
Sort By:
Pageof 11
Journal of Neuropathology and Experimental Neurology|July 29, 2024
Primary spinal cord gliomas: Pathologic features associated with prognosisYuki Tanaka, Manabu Natsumeda, Masayuki Ohashi, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|September 23, 2022
Elucidating the multiple genetic alterations involved in the malignant transformation of a KRAS mutant neurenteric cyst. A case reportShoji Saito, Manabu Natsumeda, Makoto Sainouchi, et al.Frontiers in Oncology|July 23, 2025
Case Report: Improved hearing in a rare, adult <i>IDH2</i>-mutant brainstem astrocytoma successfully treated with radiation and temozolomideTakuya Okada, Manabu Natsumeda, Hidemoto Fujiwara, et al.International Journal of Oncology|October 25, 2011
Identification and validation of a gene expression signature that predicts outcome in malignant glioma patientsAtsushi Kawaguchi, Naoki Yajima, Yoshihiro Komohara, et al.The Journal of Clinical Investigation|May 21, 2024
BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline gliomaJun Watanabe, Matthew R Clutter, Michael J Gullette, et al.Clinical Journal of Gastroenterology|February 8, 2022
Efficacy of BRAF inhibitor and anti-EGFR antibody in colorectal neuroendocrine carcinomaMae Nakano, Yoshifumi Shimada, Yoshifumi Matsumoto, et al.Acta Neuropathologica Communications|January 23, 2024
Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosisHaruhiko Takahashi, Manabu Natsumeda, Norikazu Hara, et al.Acta Neuropathologica Communications|July 27, 2019
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacyYu Kanemaru, Manabu Natsumeda, Masayasu Okada, et al.International Journal of Clinical Oncology|October 12, 2021
The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study GroupKenichiro Asano, Yoji Yamashita, Takahiro Ono, et al.Neurologia Medico-Chirurgica|October 19, 2020
Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study GroupTakahiro Ono, Toshio Sasajima, Hiroaki Shimizu, et al.Pageof 11